taigen biotechnology

TaiGen Biotechnology Co., Ltd. is a research-based and product-driven pharmaceutical company based in Taiwan. The company focuses on the discovery, development and commercialization of therapeutics to treat cancers, infectious diseases and diabetic complications (limb ischemia and retinopathy). With an executive team that has decades of experience in major multinational pharmaceutical and biotech companies and a high-quality R&D staff, TaiGen is the leading biopharmaceutical company in Asia, and is well positioned to become a major life sciences company worldwide. TaiGen currently has operations in Taiwan, China, and the U.S. TaiGen was founded in May 2001. In February 2002, TaiGen opened its state-of-the-art 40,000 square foot corporate R&D facility in the Nei-hu industrial park in Taiwan, at the center of a cluster of top research institutes. TaiGen currently employs 85 people, including 70 R&D staff. In October 2004, TaiGen established a subsidiary in China, TaiGen Biopharmaceuticals Co. (Beijing), Ltd., to conduct clinical trials and drug registration and to pave the road for marketing in that country.